CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents ($518 and $491 related to VIEs)	$ 2,912	$ 2,519
Marketable securities ($25 and $0 related to VIEs)	94	69
Accounts receivable, net ($152 and $135 related to VIEs)	1,049	1,137
Contract assets ($160 and $171 related to VIEs)	1,063	991
Other current assets ($48 and $50 related to VIEs)	147	347
Total current assets	5,265	5,063
Noncurrent assets
PP&E, net ($52 and $41 related to VIEs)	504	458
Investments	612	614
Deferred taxes	38	51
Deferred compensation trusts	223	241
Goodwill	206	206
Other assets ($80 and $127 related to VIEs)	252	340
Total noncurrent assets	1,835	1,910
Total assets	7,100	6,973
Current liabilities
Accounts payable ($319 and $285 related to VIEs)	1,195	1,214
Contract liabilities ($271 and $276 related to VIEs)	684	639
Accrued salaries, wages and benefits ($25 related to VIEs in both periods)	608	653
Other accrued liabilities ($73 related to VIEs in both periods)	495	657
Total current liabilities	2,982	3,163
Long-term debt	1,116	1,158
Deferred taxes	80	70
Other noncurrent liabilities ($82 and $20 related to VIEs)	581	530
Commitments and contingencies
Shareholders’ equity
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 171,326,177 and 170,405,512 shares in 2024 and 2023, respectively	2	2
APIC	1,286	1,228
AOCI	(298)	(269)
Retained earnings	1,261	979
Total shareholders’ equity	2,251	1,940
NCI	90	112
Total equity	2,341	2,052
Total liabilities and equity	$ 7,100	$ 6,973